4Centers for Disease Control (CDC). Revision of the CDC surveillance ease definition for acquired, immunedeficiency syndrome Council of State and Territorial Epidemiologists: AIDS Program, Center for Infectious Diseases[J]. MMWR, 1987,36(Suppl 1)1-15S.
8Bonnet F, Lew den C,M ay T,et al. M alignancyrelated causes of death in human in munodeficiency virusinfected patients in the era of high active antiretroviral therapy[J]. Cancer, 2004, 101 (2) :317-324.
5Munoz N, Bosch FX, de-Sanjose S, et al. Epidemiologic classification of human papilloma virus types associated with cervical cancer[J]. N Engl J Med, 2003,348(6): 518-527.
6Marc A, Peter S, Chris JL, et al. Clinical applications of HPV testing: A summary of metaanalyses[J].Vaccine,2006,24(S3):78-89.
7Renata CG, Sophie FM, Cecilia RM, et al. Human papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followedup for 2 years in the LAMS study[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2007, 133(2): 239-246.
8Bosch FX, Nubia M. The viral etiology of cervical cancer[J]. Virus Research, 2002, 89(2): 183-190.
9Ronco G, Valeria G, Nereo S, et al. Prevalence of human papillomavirus infection in women in Turin, Italy[J]. European Journal of Cancer, 2005, 41(2): 297-305.
10Tibor A N, La szlo K, Judit D, et al. Prevalence and risk factors of human papilloma virus infection in asymptomatic women in southeastern Hungary[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2004, 115(1): 99-100.
1Bailey CL,KeUy P, Casey PJ. Activation of Rapl promotes prostate cancer metastasis[J]. Cancer Research, 2009, 69 (12):182-187.
2Wang W,Wang H,Teng X. Clonal analysis of bilateral, recurrent,and metastatic papillary thyroid carcinomas [J] Human Pathology, 2010,41 (17) :338-344.
3Terzian T, Suh YA, Iwakuma T. The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss[J]. Genes and Development, 2008, 22(9):1281-1287.
